The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
Stéphanie Corgnac(Inserm), Fathia Mami‐Chouaib(Inserm)
Cited by 161
Related Papers
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
|Frontiers in Immunology|2018|513
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Resident memory T cells, critical components in tumor immunology
|Journal for ImmunoTherapy of Cancer|2018|333
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
|Nature Communications|2019|144
Vaccine Therapy in Non-Small Cell Lung Cancer
|Vaccines|2022|23